A Multicenter, Prospective Cohort Study in Patients with Myasthenia Gravis in China - MG Cohort

Study identifier:D9030R00001

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Recruiting

Official Title

A Multicenter, Prospective Cohort Study in Patients with Myasthenia Gravis in China

Medical condition

Myasthenia Gravis

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Estimated Enrollment

1200

Study type

Observational

Age

0 Years - n/a

Date

Study Start Date: 26 Sept 2024
Estimated Primary Completion Date: 30 Dec 2027
Estimated Study Completion Date: 30 Dec 2027

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Sept 2024 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria